Laserfiche Channel Leadership Recognized by 2024 CRN® Channel Chiefs List

 Taylor Grosso, Charles Suzara and Vicki VanValin honored for driving strategies and partnerships to drive the Laserfiche Solution Provider Program forward.

(BUSINESS WIRE)--Laserfiche — the leading SaaS provider of intelligent content management and business process automation — today announced that CRN®, a brand of The Channel Company, named three Laserfiche channel leaders to its 2024 Channel Chiefs list: Taylor Grosso, senior director of Global Channels and Alliances, Charles Suzara, associate director – west, and Vicki VanValin, vice president of sales. The prestigious CRN Channel Chiefs list, released annually, recognizes IT vendor and distribution executives who are driving strategy and setting the channel agenda for their companies.

“The IT channel has had to navigate incredible change in recent years — from economic uncertainty to the acceleration of digital transformation and rise of generative AI,” said Laserfiche CEO Karl Chan. “Laserfiche’s channel leadership has risen to the challenge of supporting our partners and empowering them to embrace these changes proactively. Taylor, Charles and Vicki are providing the channel with strategies, resources and programs that enable our partners to capture new business opportunities, solve customer problems and grow their revenue streams.”

Grosso manages Laserfiche’s global channel sales team, focusing on channel growth and providing solution providers with the necessary support to develop, manage and maximize sales opportunities. He has developed a sales model that emphasizes relevant and timely educational opportunities, training and support for channel partners.

Suzara is responsible for a team of channel managers covering 25 states, representing a diverse range of channel partners and industries served. As Laserfiche expands its footprint in the enterprise space, Suzara has been instrumental in working with channel partners to approach larger organizations with more complex needs, while still supporting some of the company’s newest partners in getting up and running quickly.

VanValin joined Laserfiche in 2023, bringing 25 years of experience in sales leadership and business development for global technology companies. During her time at Laserfiche, she has driven key changes to the company’s channel program in response to changing market needs, to set channel partners up for sustainable success. Under her leadership, Laserfiche is modernizing its channel partner program while building a thriving channel partner ecosystem that provides expanded resources and capabilities, enhances customer loyalty and encourages innovation.

“These channel evangelists are dedicated to supporting solution providers and achieving growth by implementing robust partner programs and unique business strategies,” said Jennifer Follett, VP, US Content, and executive editor, CRN, at The Channel Company. “Their efforts are instrumental in helping partners bring essential solutions to market. The Channel Company is pleased to acknowledge these prominent channel leaders and looks forward to chronicling their achievements throughout the year.”

The Channel Chiefs list showcases the top leaders throughout the IT channel ecosystem who work tirelessly to ensure mutual success with their partners and customers.

CRN’s 2024 Channel Chiefs list will be featured in the February 2024 issue of CRN® Magazine and online at www.CRN.com/ChannelChiefs.

To learn more about the Laserfiche Solution Provider Program, visit laserfiche.com/partners/solution-provider-program/.

About Laserfiche

Laserfiche is the leading SaaS provider of intelligent content management and business process automation. Through powerful workflows, electronic forms, document management and analytics, the Laserfiche® platform accelerates how business gets done, enabling leaders to focus on growth across the enterprise.

Laserfiche pioneered the paperless office with enterprise content management. Today, Laserfiche’s cloud-first development approach incorporates innovations in machine learning and AI to enable organizations in more than 80 countries to transform into digital businesses. Customers in every industry — including government, education, financial services, healthcare and manufacturing — use Laserfiche to boost productivity, scale their business and deliver digital-first customer experiences.

Laserfiche employees in offices around the world are committed to the company’s vision of empowering customers and inspiring people to reimagine how technology can transform lives.

Connect with Laserfiche:

Laserfiche Blog | Twitter/X | LinkedIn | Facebook

About The Channel Company

The Channel Company enables breakthrough IT channel performance with our dominant media, engaging events, expert consulting and education, and innovative marketing services and platforms. As the channel catalyst, we connect and empower technology suppliers, solution providers and end users. Backed by more than 40 years of unequalled channel experience, we draw from our deep knowledge to envision innovative new solutions for ever-evolving challenges in the technology marketplace. http://www.thechannelcompany.com/

Follow The Channel Company: Twitter, LinkedIn, and Facebook.

© 2024. CRN is a registered trademark of The Channel Company, LLC. All rights reserved.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240206729035/en/

Permalink

https://aetoswire.com/en/news/6022024374899

Contacts

Media Contact:

Linda Domingo

Director, Public Relations, Laserfiche

Linda.domingo@laserfiche.com

562-988-1688 ext. 234

The Channel Company Contact:

Natalie Lewis

The Channel Company

nlewis@thechannelcompany.com

Parse Biosciences Partners with INTEGRA Biosciences for Automated Single Cell Workflows

SEATTLE - Tuesday, 06. February 2024

Automation to enable increased facility for single cell projects

(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has entered into an agreement with INTEGRA Biosciences to integrate the Assist Plus with built-in Parse Evercode™ single cell protocols. Combining the scale of the Parse technology with the semi-automated liquid handling of the Assist Plus will significantly reduce hands-on time while further increasing throughput and efficiency of the workflow. As part of the agreement, Parse will sell a bundled solution composed of Evercode single cell reagents and an application-enabled INTEGRA Assist Plus instrument directly to customers.

“The INTEGRA Assist Plus will allow scientists to seamlessly profile many millions of cells per week and reduce hands-on time by as much as 80%,” said Charlie Roco, Parse co-founder and CTO. He added, “The first Parse products enabled on the Assist Plus will be Evercode Whole Transcriptome kits. We look forward to evolving this offering, building a growing library as applications and additional product support expand.”

The move supports Parse’s efforts to dramatically expand the single cell market by providing cost effective, instrument-agnostic, and accessible single cell sequencing solutions. The Assist Plus is an easy-to-use instrument, trusted worldwide by thousands of laboratories. As part of the deal, Parse customers will be supported by both the Parse Biosciences and INTEGRA field service and sales teams.

“INTEGRA is excited to partner with Parse to provide the instrumentation, installation and training, and field service capabilities to enable Parse and Parse's customers with reliable and rapid pre-sales and post-sales support,” said Larry Keene, INTEGRA SVP of Strategic Sales. He added, “The collaboration between the two organizations will bring great value to Parse's customers."

The Parse Biosciences team will be presenting a poster on the efficiency gained by integrating the INTEGRA Assist Plus with the Evercode protocols at the Society for Laboratory Automation and Screening (SLAS) conference in Boston February 3-7.

About Parse Biosciences

Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, its pioneering approach is enabling groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.

Founded based on a transformative technology invented at the University of Washington, Parse has raised over $100 million and is used by over 1,500 labs across the world. Its growing portfolio of products includes Evercode Whole Transcriptome, Evercode TCR, Gene Capture, CRISPR Detect, and a software tool for data analysis.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240206643616/en/

Permalink

https://www.aetoswire.com/en/news/20240206643616r1

Contacts

 

Jay Roberts, SRPR

jay@shevrushpr.com | 917.696.2142

ExaGrid Recognized in the “2024-25 DCIG TOP 5 2PB+ Cyber Secure Backup Target Global Edition Report

  

ExaGrid EX189 named as only scale-out backup target to achieve a TOP 5 ranking in Report

(BUSINESS WIRE)--ExaGrid®, the industry’s only Tiered Backup Storage solution, today announced that its EX189 appliance has been recognized as a TOP 5 backup target in the 2024-25 DCIG TOP 5 2PB+ Cyber Secure Backup Target Global Edition Report.

The report from DCIG provides guidance on the TOP 5 cyber secure backup targets that enterprises should consider in their fight against ransomware. The report includes a profile of each of the TOP 5 cyber secure backup targets which lists at least three ways each backup target distinguishes itself from the other solutions.

Inclusion Critieria for the 2024-25 DCIG TOP 5 2PB+ Cyber Secure Backup Target Global Edition1 report:

• Offers cyber security features to protect itself and data stored on it.
• Scales to at least two petabytes of raw storage capacity.
• Ships as a physical appliance.
• Shipping and available by January 1, 2024.
• Sufficient information available for DCIG to make an informed, defensible decision.

ExaGrid’s EX189, the largest appliance model in the line of ExaGrid Tiered Backup Storage appliances, achieved its TOP 5 ranking due it its unique scale-out architecture and its comprehensive security features such as Retention Time-Lock for Ransomware Recovery, including a non-network-facing tier (tiered air gap), with a delayed delete policy and immutable data objects. In addition, ExaGrid’s industry-leading customer support model of customers working directly with a level-2 senior support engineer is also highlighted in the report as a key differentiator from other backup targets.

“ExaGrid is pleased to be named in DCIG’s TOP 5 Report,” said Bill Andrews, President and CEO of ExaGrid. “Traditionally, backup applications have strong security but backup storage typically has little to none. ExaGrid is unique in its approach to backup storage security and we encourage all organizations to consider their approach to backup storage when evaluating their cybersecurity policies and procedures and overall readiness to recover if faced with a ransomware attack.”

1 DCIG, “2024-25 DCIG TOP 5 2PB+ Cyber Secure Backup Target – Global Edition,” February 1 2024, Jerome M. Wendt.

About ExaGrid

ExaGrid provides Tiered Backup Storage with a unique disk-cache Landing Zone, long-term retention repository, and scale-out architecture. ExaGrid’s Landing Zone provides for the fastest backups, restores, and instant VM recoveries. The Repository Tier offers the lowest cost for long-term retention. ExaGrid’s scale-out architecture includes full appliances and ensures a fixed-length backup window as data grows, eliminating expensive forklift upgrades and product obsolescence. ExaGrid offers the only two-tiered backup storage approach with a non-network-facing tier, delayed deletes, and immutable objects to recover from ransomware attacks.

ExaGrid has physical sales and pre-sales systems engineers in the following countries: Argentina, Australia, Benelux, Brazil, Canada, Chile, CIS, Colombia, Czech Republic, France, Germany, Hong Kong, India, Israel, Italy, Japan, Mexico, Nordics, Poland, Portugal, Qatar, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Turkey, United Arab Emirates, United Kingdom, United States, and other regions.

Visit us at exagrid.com or connect with us on LinkedIn. See what our customers have to say about their own ExaGrid experiences and learn why they now spend significantly less time on backup storage in our customer success stories. ExaGrid is proud of our +81 NPS score!

ExaGrid is a registered trademark of ExaGrid Systems, Inc. All other trademarks are the property of their respective holders.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240206750165/en/

Permalink

https://www.aetoswire.com/en/news/6022024374844

Contacts

Media:

Mary Domenichelli

ExaGrid

mdomenichelli@exagrid.com

 

Citi Global Wealth Investments Issues Mid-Year Wealth Outlook 2023 - Opportunities on the Horizon: Investing Through a Slowing Economy

 

NEW YORK

(BUSINESS WIRE) -- Citi Global Wealth Investments today released its Mid-Year Wealth Outlook 2023 report - Opportunities on the Horizon: Investing Through a Slowing Economy. This biannual report sets out Citi Global Wealth’s outlook on how investors should approach developments in the global economy, markets and geopolitics.

Though 2023 has been full of extraordinary events, Citi Global Wealth sees the remainder of the year as an opportunity. We are in a “rolling recession” where parts of the US economy are growing even as others contract. As inflation slowly eases following a period of rapid Fed rate hikes, the group believes that keeping portfolios invested is imperative. While the current asset allocation strategy remains defensive, Citi Global Wealth see numerous opportunities to adjust their portfolios over time, as the Fed shifts from interest rate hikes to cuts.

We believe that current markets will lead into a meaningful potential recovery in 2024.

“Though the broader bear market is not yet over, we are seeing significant valuation improvements in certain sectors that provide our clients with the potential to invest in higher income-generating assets and long-term growth opportunities,” said David Bailin, Chief Investment Officer at Citi Global Wealth. “Our wealth outlook for the remainder of 2023 and heading into 2024 suggests that clients may benefit most from a return to what we call ‘core investing’ – full invested portfolios that move from defense to offense, from more bonds to more equities, from US-focused to global. We favor investing in select non-U.S. equities, identifying value within U.S. markets, broadening tech and growth equity exposures and emphasizing alternative investing and private credit for suitable investors with a longer time horizon.”

Bonds are Back Again: Sustaining Income as Rates Peak

Citi Global Wealth believes that it is time for action in the fixed income space. Investors holding short term investments can seek to extend their income by extending duration. There are also many potential opportunities to diversify bond portfolios, add to duration, diversity risk and earn potentially higher yields. And private credit can add significant yield as banks retrench. Best of all, bonds will now provide the diversification benefits they lost temporarily in 2022.

Diversity Currency Exposure

The U.S. dollar (USD) rose for a decade through 2022 and saw a boost from excessive Fed tightening and energy shocks related to the war in Ukraine. The rise in the USD sharply inflated US home-biased portfolios verses portfolios holding other currencies. US equities rose to 63% of the global market cap in 2022.

As the ECB and other central banks hold rates steady in 2024 while the Fed eases, there can be opportunities for clients to diversify into non-USD assets, seeking to improve investor returns in the decade ahead.

“The strong U.S. dollar means we can buy non-U.S. assets at deeply deflated prices,” said Steven Wieting, Chief Economist and Chief Investment Strategist at Citi Global Wealth. “While we expect periodic US dollar rallies, we ultimately will see a weakening dollar, making currency exposure more critical. In addition to currency exposure, we are favoring quality, such as long-duration bonds to offset a potential credit spread widening and defensive equities with an emphasis on dividend growers and companies with strong balance sheets. As we prepare portfolios for the Fed pivot at the end of 2023, we look for industry-leading growth shares to bottom before cyclicals.”

Unstoppable Trends

Citi Global Wealth’s “Unstoppable Trends” are transformative global forces that can inform change in client portfolios.

The Mid-Year Wealth Outlook 2023 defines the following trends:

Digitization - Generative AI is the beginning of (another) technological revolution: the rapid adoption of AI opens the door to significant investment opportunities in the ecosystem

Energy Security: Unusual opportunities in an atypical energy cycle: World events and the rise of renewable energy are reshaping the energy landscape

G2: Putting national security interests ahead of economic cooperation: Intensifying U.S.-China tension creates challenges and opportunities for investors

Invest in Longevity: Healthcare demand continues to grow faster than the world economy, proving non-cyclical growth for portfolios

See Citi Global Wealth’s full Mid-Year Wealth Outlook report for full details.

About Citi Global Wealth

Citi Global Wealth is an integrated wealth management platform that delivers a total wealth solution to clients across the wealth continuum, with integrated advice and execution across both their assets and liabilities. Citi Global Wealth serves ultra-high-net-worth individuals and family offices through Citi Private Bank, operates in the affluent and high-net worth segments through Citigold® and Citigold Private Client and captures wealth management in the workplace through Global Wealth at Work. Citi Global Wealth provides clients with a leading investment strategies platform, which delivers traditional and alternative investments, managed account strategies and investment guidance for all clients.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20230608005793/en/

Permalink

https://www.aetoswire.com/en/news/0906202332757

Contacts

Media:

North America: Jamie Letica

LATAM: Denise Rockenbach

APAC: Harsha Jethnani

TauRx to Present Two-Year Data from Phase III Trial of HMTM in Alzheimer’s Disease at the AD/PD™ 2024 Conference in March

 ABERDEEN, Scotland 

(BUSINESS WIRE)--TauRx Pharmaceuticals Ltd., a global leader in Tau-based research in Alzheimer’s disease (AD), announced today that the company will present the 24-month data from its Phase III LUCIDITY trial of hydromethylthionine mesylate (HMTM) at the upcoming AD/PD™ 2024 Alzheimer's & Parkinson's Diseases Conference from 5-9 March 2024, in Lisbon, Portugal.

Professor Claude Wischik, Co-Founder, CEO and Executive Chairman of TauRx will present data including details of the final 12-month open label phase of the study indicating maintenance of subjects with mild cognitive impairment due to Alzheimer’s at baseline cognitive scores. A panel, moderated by Dr. Serge Gauthier and including Professor Henrik Zetterberg, Professor Alistair Burns, and Dr. David Watson, will discuss the relevancy of these data and the potential impact of HMTM on people living with Alzheimer’s.

“We believe that presentation and discussion of this data represents an important step in our mission to bring people living with Alzheimer’s and their loved ones a safe and effective oral treatment that they will be able to access,” said Professor Claude Wischik. “Alzheimer’s is a global problem, one that impacts millions of people in some way at some point, and we are determined to help those impacted by this disease.”

HMTM is designed for early intervention to modify the disease, slowing progression of AD. If approved, HMTM will be the first oral, anti-tau therapy with a robust safety profile requiring minimal testing and treatment monitoring. This simplified profile will promote accessibility and affordability for people living with Alzheimer’s.

At the conference, TauRx will present the data during a moderated panel discussion at 13:50 CET on 7 March (Abstract #2363; “24-month topline results from Phase III LUCIDITY trial in AD show combined disease-modifying and symptomatic activity for HMTM”) and host an additional question and answer session on 9 March. Professor Wischik will also participate in a forum discussion “Anti-tau therapies in clinical trials—what are the challenges and opportunities for a rational therapy?” on 8 March.

TauRx has initiated regulatory engagement in the UK and the US for intended product approval. Other territories will follow in line with plans to scale commercialisation of HMTM.

For additional information, please visit: https://taurx.com/ or https://adpd.kenes.com/.

TAU PATHOLOGY IN ALZHEIMER’S

Through dedicated research programs, it is understood that certain age-related factors lead to misfolding and aggregation of tau proteins, and the subsequent formation of tau tangles in Alzheimer’s. Pathological aggregation of tau protein disrupts and damages neuronal function. The process begins many years before symptoms of dementia are seen. Tau pathology has been proven to correlate with the clinical decline (loss of memory and ability to care for oneself) commonly seen in people with Alzheimer’s, establishing it as an important target for treatment. HMTM is primarily a tau aggregation inhibitor, which effectively crosses the blood brain barrier to target the source of this damaging process. Its secondary pharmacological action is symptomatic through increasing acetylcholine levels in parts of the brain essential for memory functions.

ABOUT LUCIDITY

Completed in June 2023, LUCIDITY was a double-blind randomised controlled Phase III clinical trial comparing change over 12 months in cognitive, functional and brain atrophy outcomes at HMTM doses of 16 mg/day, 8 mg/day and methylthioninium chloride (MTC) at a dose of 4 mg twice weekly as a control in a 4:1:4 randomisation, with a subsequent 12 month blinded open-label extension phase in which all participants received 16 mg/day.

ABOUT TAURx PHARMACEUTICALS LTD

TauRx was founded in 2002 in Singapore, with primary research facilities and operations based in Aberdeen, UK. The company has dedicated the past two decades to developing treatments and diagnostics for Alzheimer’s and other neurodegenerative diseases due to pathological aggregation of tau and other proteins.

Alzheimer’s disease is a leading cause of disability and death throughout the world and is one of the most important global public health issues. TauRx will contribute to addressing this unmet need with data from LUCIDITY and pursuit of regulatory approvals in line with its overall plans to make HMTM available for people living Alzheimer’s. Future research is planned for other related neurodegenerative diseases. https://taurx.com/

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240205168572/en/

Permalink

https://www.aetoswire.com/en/news/5022024374544

Contacts

Kirstie Rennie

Kirstie.rennie@weareaspect.com

 

Jefferies Agrees Sale of OpNet Operations to Wind Tre, Substantially Completing Jefferies’ Strategic Simplification Plan

 NEW YORK - Monday, 05. February 2024

Proceeds Modestly Higher Than Current Carrying Values

(BUSINESS WIRE) -- Jefferies Financial Group Inc. (NYSE: JEF) announced today that, consistent with its strategy to build the leading independent global Investment Banking and Capital Markets firm, Jefferies agreed to the sale by OpNet S.p.A (the Italian wireless broadband provider formerly known as Linkem) of substantially all of OpNet’s operations to Wind Tre S.p.A., a subsidiary of CK Hutchison Group Telecom Holdings Ltd. (CKHGT).

Under the terms of this sale agreement, the consideration will be €485 million, subject to certain adjustments, that will consist of cash in an amount sufficient to satisfy all of OpNet’s financial debt, transaction costs and other cash obligations and approximately €225 million to be paid also in cash or, at CKHGT’s election, in three-year notes issued by CKHGT that are similar to CKHGT’s publicly listed investment-grade bonds and are marketable. In addition to the consideration of the CKHGT notes, OpNet will retain majority ownership in other operating telecom companies, resulting in approximately €320 million in final value to Jefferies from this transaction, which exceeds our current carrying value. This sale is subject to regulatory approvals and is anticipated to close in the second or third quarter of 2024.

Jefferies recently agreed to sell Foursight Capital LLC (an automobile finance company) to One Main Holdings, Inc. (NYSE:OMF), and Golden Queen (a gold and silver mining company) to Andean Precious Metals (TXV:APM).

To reflect the completion of the substantial reduction of these legacy investments, Jefferies will reclassify the remaining legacy investments as “Other investments” in its Asset Management reportable segment in fiscal 2024. The only individual investment of size today is HomeFed, our real estate development company that specializes in mixed-use, master-planned communities. We expect to operate the core business of HomeFed, which has solid long-term prospects, and to liquidate certain peripheral assets in an orderly manner.

Rich Handler, CEO of Jefferies, and Brian Friedman, President of Jefferies, commented: “After over a decade of optimizing and efficiently monetizing our merchant banking assets and using the proceeds to reinvest in Jefferies and return capital to our shareholders, we are thrilled to be back to our roots of focusing exclusively on building the very best ‘pure play’ global investment banking firm. With the support of our more than 5,500 employee-partners worldwide, we have been able to achieve our goal of focusing Jefferies’ efforts on our core business, becoming a leader around the world in Investment Banking and Capital Markets. And we believe our human capital investment to broaden and deepen our capabilities, together with our Strategic Alliance with SMBC, position us well as we move forward in 2024 and the years beyond.”

About Jefferies

Jefferies (NYSE: JEF) is a leading global, full-service investment banking and capital markets firm that provides advisory, sales and trading, research, wealth, and asset management services. With more than 40 offices around the world, we offer insights and expertise to investors, companies and governments. For more information: www.jefferies.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements about our future and statements that are not historical facts. These forward‐looking statements are typically identified by such words as “believe,” “expect,” “anticipate,” “may,” “intend,” “outlook,” “will,” “estimate,” “forecast,” “project,” “should,” and other similar words and expressions, and are subject to numerous assumptions, risks and uncertainties, which will change over time. Forward-looking statements may contain beliefs, goals, intentions and expectations regarding revenues, earnings, operations, arrangements and other results, and may include statements of future performance, plans, and objectives. Forward-looking statements also include statements pertaining to our strategies for future development of our businesses and products. Forward‐looking statements speak only as of the date they are made; we do not assume any duty, and do not undertake, to update any forward‐looking statements. Furthermore, because forward‐looking statements represent only our belief regarding future events, many of which by their nature are inherently uncertain, the actual results or outcomes may differ, possibly materially, from the anticipated results or outcomes indicated in these forward-looking statements. Information regarding important factors, including Risk Factors that could cause actual results or outcomes to differ, perhaps materially, from those in our forward-looking statements is contained in reports we file with the SEC. You should read and interpret any forward-looking statement together with reports we file with the SEC. Past performance may not be indicative of future results. Different types of investments involve varying degrees of risk. Therefore, it should not be assumed that future performance of any specific investment or investment strategy will be profitable or equal the corresponding indicated performance level(s).

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240131906401/en/

Permalink

https://www.aetoswire.com/en/news/0502202437460

Contacts

Media Inquiries

Jonathan Freedman (212) 284-2300

MediaContact@Jefferies.com

PUMA to Supply Egypt With Athletic Uniforms at the Olympic Games

 HERZOGENAURACH, Germany - Monday, 05. February 2024 AETOSWire 

(BUSINESS WIRE) -- Sports company PUMA will equip the athletes, coaches and staff of the Arab Republic of Egypt with athletic uniforms at the Paris 2024 Olympic Games, following an agreement with the Egyptian Ministry of Youth and Sports and the Egyptian Olympic Committee.

PUMA has a successful history in Egypt with long-term partnerships, including those with the Egyptian Football Association, the Egyptian Handball Federation and other teams and athletes. Most recently, PUMA team Egypt won the African Men's Handball Championship for the ninth time and qualified for the Olympic tournament.

“For PUMA, the agreement represents a great opportunity to further invest in sports in Egypt and to strengthen our presence in the country. Egypt has a deeply rooted passion for sports and great economic potential. As a sports company, we are excited to invest in both," said Johan Kuhlo, Managing Director EEMEA Distribution.

As part of the agreement, the Egyptian delegation will wear PUMA products including apparel, footwear and accessories during the Games. The most recent Olympic Games in Tokyo were the most successful in the Egypt’s history with six medals.

“In PUMA we have found a perfect partner who is as passionate about sports in Egypt as we are. PUMA is already well known to Egyptians as a reliable partner for our national football and handball teams and I am proud the company will now also outfit our Olympic delegation for the upcoming Games in Paris,” said Prof. Dr. Ashraf Sobhy, the Egyptian Minister of Youth and Sports.

PUMA

PUMA is one of the world’s leading sports brands, designing, developing, selling and marketing footwear, apparel and accessories. For 75 years, PUMA has relentlessly pushed sport and culture forward by creating fast products for the world’s fastest athletes. PUMA offers performance and sport-inspired lifestyle products in categories such as Football, Running and Training, Basketball, Golf, and Motorsports. It collaborates with renowned designers and brands to bring sport influences into street culture and fashion. The PUMA Group owns the brands PUMA, Cobra Golf and stichd. The company distributes its products in more than 120 countries, employs about 20,000 people worldwide, and is headquartered in Herzogenaurach/Germany.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240205371327/en/

Permalink

https://www.aetoswire.com/en/news/0502202437459

Contacts

Robert-Jan Bartunek

PUMA Corporate Communications

robert.bartunek@puma.com